Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker

[1]  M. Goldberg,et al.  Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells , 2016, Oncotarget.

[2]  Clotilde Théry,et al.  Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles , 2013, Journal of Cell Science.

[3]  S. Aliño,et al.  Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics , 2012, PloS one.

[4]  M. Agostini,et al.  Telomere-Specific Reverse Transcriptase (hTERT) and Cell-free RNA in Plasma as Predictors of Pathologic Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy , 2012, Annals of Surgical Oncology.

[5]  Arsen O. Batagov,et al.  Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles , 2011, BMC Genomics.

[6]  C. Théry.  Exosomes: secreted vesicles and intercellular communications , 2011, F1000 biology reports.

[7]  M. Kudo,et al.  A novel biomarker TERTmRNA is applicable for early detection of hepatoma , 2010, BMC gastroenterology.

[8]  M. Agostini,et al.  Relationship Between Tumor and Plasma Levels of hTERT mRNA in Patients with Colorectal Cancer: Implications for Monitoring of Neoplastic Disease , 2008, Clinical Cancer Research.

[9]  José Miguel García,et al.  Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. , 2008, RNA.

[10]  M. Kudo,et al.  Development of a Novel Assay to Quantify Serum Human Telomerase Reverse Transcriptase Messenger RNA and Its Significance as a Tumor Marker for Hepatocellular Carcinoma , 2007, Oncology.

[11]  A. Burger,et al.  Telomerase and its potential for therapeutic intervention , 2007, British journal of pharmacology.

[12]  N. Miura,et al.  Serum Human Telomerase Reverse Transcriptase Messenger RNA as a Novel Tumor Marker for Hepatocellular Carcinoma , 2005, Clinical Cancer Research.

[13]  T. Godfrey,et al.  Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. , 2004, Clinical chemistry.

[14]  M. A. Goldman.  The role of telomeres and telomerase in cancer. , 2003, Drug discovery today.

[15]  Y. Lo,et al.  Stability of endogenous and added RNA in blood specimens, serum, and plasma. , 2002, Clinical chemistry.

[16]  J. Garcia-conde,et al.  Real-Time Quantification in Plasma of Human Telomerase Reverse Transcriptase (hTERT) mRNA: A Simple Blood Test to Monitor Disease in Cancer Patients , 2001, Laboratory Investigation.

[17]  Z. Darżynkiewicz,et al.  Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. , 2000, Experimental cell research.

[18]  H. Stein,et al.  [Telomerase as a tumor marker?]. , 1997, Verhandlungen der Deutschen Gesellschaft fur Pathologie.